FROM IDEA TO RESULTS

Imagine all the digital data ever created — every website, photo, video, and AI model — it all fits in 1 grain of sand. If that’s the case, then Earth’s physical data would fill 20 planets covered in sand. Physical data is massive, and allows humanity to create miraculous new discoveries.

But discoveries and new physical data creation is historically slow. Edison spent 8 years on electric lighting. Fleming spent 12 years on penicillin. Now you can create 10 types of material in 5–90 minutes on 1 platform, with real physical results in 24 hours — and produce large amounts of high quality data.

Our Vision

We believe the most important goal for humanity is to evolve beyond Homo Sapiens — a new species capable of living thousands of years, biologically connected to AI, access to unlimited energy, traveling at near light-speed, living across multiple planets.

To accomplish this, we will create an AI Scientist that creates large amounts of new physical data. Anyone can create digital simulations and physical material, using our proprietary AI systems, quantum models, and robotic automation labs. This will democratize new discoveries globally for individuals, businesses, and governments.

We cover 10 major industries: drugs, batteries, catalysts, space energy, semiconductors, solar energy, nuclear energy, hypersonic, armor, and stealth.

Footnote: Digital Data: ~200 zettabytes (~1.6 × 10²⁴ bits) — IDC Global DataSphere, 2026. Earth’s atomic content: ~1.3 × 10⁵⁰ atoms — standard astrophysics.

An elite team
changing science.

TakaHuman has gathered an elite, international team of scientists, engineers, and operators — spanning academia and industry across 4 continents. The team brings together world-class expertise in quantum AI, computational chemistry, knowledge graphs, drug discovery, laboratory automation, robotic systems, photovoltaics, computer vision, systems pharmacology, and software engineering.

Our scientists and engineers hold PhDs and senior positions from Yale, Cambridge, Caltech, IIT Delhi, IIT Kharagpur, University of Stuttgart, Michigan State University, University of Southern California, and UCSF. They have held leadership and senior roles at Amazon, GSK, Bristol-Myers Squibb, Plug Power, Tandem PV, Intel, Toyota Research Institute, KLA, POLARISqb, Astellas, and Microsoft.

Dan Takahashi
Dan Takahashi
Founder & CEO
Dan graduated from Cornell University in approximately 3 years with Magna Cum Laude honours. He previously founded MNS International (a hedge fund) and PostPrime (a social media platform that achieved an IPO within ~2.5 years on the Tokyo Stock Exchange). He has lived in 7 countries and travelled to 62, and became a social media influencer almost by accident — despite not being a fluent Japanese speaker — building over 1 million followers and appearing occasionally on national television in Japan for interviews. He spent 1.5 years rigorously testing business ideas before committing to TakaHuman — the path he identified as the highest-value contribution he could make to humanity.
Shayoni Dutta
Shayoni Dutta
Data & Semantic Science Lead · Knowledge Graph Specialist
Shayoni is a quantitative, semantic modeling, and data science leader with 14 years of experience (10+ years post-PhD) across pharma, biotech, and healthcare analytics. She holds a PhD in Artificial Intelligence from IIT Delhi and most recently served as Data Science Manager at GSK.

She is a specialist in knowledge graph architecture — lead architect of knowledge graph–driven and agentic AI frameworks integrating RDF knowledge graphs, causal inference, and LLM systems for decision intelligence. Her expertise further spans pharmacometrics, QSP/PK-PD/DMPK/ADME modelling, multiomics integration, Bayesian modelling, Monte Carlo simulation, reinforcement learning, and graph AI — applied across drug discovery, oncology, and enterprise-scale operational intelligence.

Shayoni has 8 published scientific papers, is a Stanford WiDS Regional Ambassador, an NVIDIA Deep Learning Institute certified practitioner, and a Sakura Fellow (Japan-Asia Youth Exchange Program in Science).
Anonymous team member
Sr. Director of Research Automation
Pharma Lab Automation · Robotics · Drug Discovery Operations
A research automation leader with 20+ years of experience in the pharmaceuticals industry, spanning large molecules, B cell line development, NGS, molecular rescue, genotyping, protein chemistry, CRISPR, cell line development, and drug discovery.

Expert in building labs with lean automation and turnkey systems for both large and small molecule workflows, with skills in Verification & Validation (V&V), Good Laboratory Practice (GLP), robot fleet management, change control, and oncology. This team member has chosen to keep their personal details private at this time.
Jason Winkler
Jason Winkler
Chief Revenue Officer · Sales, Strategy & Go-to-Market Execution
Jason is a Chief Revenue Officer and Sr. Vice President of Sales, Strategy & Operations with 15+ years of experience leading global deal origination, revenue strategy, and go-to-market execution across enterprise technology and regulated industries. He currently serves as Vice President of Global Sales & Alliances at Zaether and Kynota (Stellix Group companies) and as Senior Advisor to The Stellix Group, helping life sciences organisations turn disruption into opportunity through digital strategy, applied technology, and outcome-driven consulting.

He previously founded and chaired SAS International, providing real estate investment and strategic consulting to start-ups, PE- and VC-backed companies, and hyper-growth businesses across medical devices, life sciences, pharma manufacturing, surgical robotics, IoT cybersecurity, and smart agriculture. Earlier, as Vice President of Sales & Business Development at Device Authority, he led enterprise sales, marketing, and BD for the Americas, scaling adoption of the KeyScaler IoT identity and access management platform across life sciences, healthcare, government, and industrial verticals. Jason holds a BS in Biology with a minor in Chemistry from the University of North Carolina at Chapel Hill and completed the Carolina Business Institute programme at UNC Kenan-Flagler Business School.
B. Maurice Benson
B. Maurice Benson
Principal Software Engineer · Quantum Computing & AI
Maurice is a senior software engineer with 17+ years of experience, including 10+ years in AI-driven solutions and 5 years in quantum computing. He holds an MS in Computer Science from the University of North Carolina Wilmington, where his thesis paper won the 2010 SE DSI Best Article Award.

He currently serves as Principal Software Engineer at POLARISqb, where he collaborates with industry leaders to revolutionise preclinical drug discovery — reducing lead times from 5 years to just 4 months by leveraging D-Wave quantum annealers, Google Cloud, and AI-driven quantum optimisation pipelines to accelerate drug blueprint generation at scale.

Previously at Fearless (Baltimore) as Technical Lead and Senior Software Developer, he led machine learning and NLP projects across distributed computing platforms, designed containerised NLP pipelines for large-scale unstructured data processing, and collaborated with interdisciplinary teams of scientists and supply chain analysts. He is expert in Python, Docker, GCP, CI/CD, vector databases, MLOps, and quantum optimisation, and is recognised as a thought leader in quantum computing and AI with multiple publications, presentations, and awards.
Tridip Das
Tridip Das
Computational Material Scientist · Staff Scientist, Caltech
Tridip is a computational material scientist at Caltech developing new materials from first principles. He holds a PhD in Chemical Engineering from Michigan State University (GPA 3.71) and an M.Tech from IIT Kharagpur (GPA 9.70/10).

His expertise spans DFT, molecular dynamics, thermodynamics modelling, and ML applied to materials — batteries, semiconductors, catalysts, and CO2 capture. He previously worked as Process Engineer at Intel Corporation and Co-op Research Scientist at the Toyota Research Institute. He has 16 published papers including in Nature Communications, supported by a $694K DOE grant. He holds a Six Sigma Black Belt.
Anonymous team member
Stephen A. Adeoye, Ph.D.
Thermal Packaging Engineer · Semiconductor Packaging & Electronics Cooling
Stephen is a thermal packaging engineer with a Ph.D. in Mechanical Engineering and 8+ years of combined professional and academic experience in semiconductor packaging, advanced package thermal management, electronics cooling, and system-level thermal architecture. He currently works at Intel Corporation as a Thermal Packaging Engineer on Optical & Advanced Packaging Systems, owning end-to-end Gen 2 optical packaging development supporting heterogeneous integration and chiplet-based systems for high-volume manufacturing.

At Intel, he has reduced insertion loss by 30% through package redesign and process optimisation, cut cure-temperature error by ~30% through CFD/FEA simulation, and reduced package delamination risk by 50% through thermal cycling and reliability qualification. He holds a Ph.D. in Mechanical Engineering (ThermoFluids | Heat and Mass Transfer) from the University of Central Florida, where his doctoral research included designing a high-pressure, high-temperature supercritical CO₂ test rig for microelectronics thermal management and proposing a new correlation for area-averaged Nusselt number. He previously interned at Rivian Automotive on HVAC and defog/defrost thermal control models. Stephen is skilled in CFD/FEA simulation (ANSYS Fluent, Icepak, COMSOL), thermal interface engineering, and manufacturing scale-up.
Mamdudur R.
Mamdudur R.
Mechanical Engineer · Structural Dynamics & Advanced Manufacturing
Mamdudur is a mechanical engineer and PhD candidate in Mechanical Engineering at the University of South Carolina, specialising in structural dynamics, solid mechanics, phononics, and advanced manufacturing. His research focuses on mechanical simulation, dynamic behaviour of engineered structures, and advanced materials systems, with an emphasis on connecting computational modelling to practical engineering applications.

Before his doctoral studies, he worked as a Mechanical Design Engineer at CAE SoftSys, Inc. (Texas), leading mechatronic design projects across aerospace, automotive, and HVAC sectors — including upgrading the Boeing 737 Landing Gear Door Retract System from a mechanical mechanism to a mechatronic control system in CATIA V5, and delivering a $100K project that improved operational efficiency by 50%. He also conducted research at the University of Texas at Arlington Research Institute (UTARI), contributing to the development of SLA 3D-printed coaxial nozzles for piezoelectric nanofibre manufacturing, while pursuing a BSc in Mechanical Engineering with a Nuclear Engineering minor. Mamdudur is proficient in SOLIDWORKS, CATIA, ANSYS, ABAQUS, Python, and MATLAB, and holds Dassault Systèmes certifications in CATIA, Aerospace & Defense, Automotive, and Industrial Equipment.
Anonymous team member
Principal Scientist · Drug Discovery & Screening
High-Throughput Screening · Biochemistry · Translational Research
A discovery team leader and screening scientist with over two decades of industry and institutional experience in drug discovery, translational research, and core facility administration. Holds a PhD in Biochemistry from the University of Cambridge and an MSc in Biological Research Methods from the University of Exeter.

Previously spent nearly 12 years at a leading US academic medical centre as Academic Administrator and Senior Biologist, coordinating more than 20 national and international academic screening projects — with one programme spawning a venture-funded start-up — and leading 6 industry partnerships in high-throughput screening, high-content image analysis, and biophysical fragment screening. Earlier, served as Senior Scientist at a drug discovery biotech and as a Postdoctoral Research Fellow at a leading US university (School of Medicine). Currently serving as Principal Scientist at an early-stage biotech. This team member has chosen to keep their personal details private at this time.
Joseph Kangas
Joseph Kangas
Neural ODE & PINNs Specialist · Computational Biophysics · University of Minnesota
Joseph is a senior research faculty member at the University of Minnesota with a PhD in Mechanical Engineering and more than 10 years of experience developing computational and mathematical models for biological systems.

His work focuses on the development and application of PDEs, ODEs, Neural ODEs, and Physics-Informed Neural Networks (PINNs) to problems in crystallisation, glass formation, biotransport, cellular toxicity, biostabilisation, and cryopreservation. He also develops multiphysics models, optimisation methods, and data-inversion techniques that connect mathematical theory with experiments in physical and biological systems.
Basel Mansour
Basel Mansour
Computational & Medicinal Chemist · Drug Design · ADMET · Free Energy Perturbation
Basel is a computational and medicinal chemist with dual doctoral training — a PhD in Computational & Medicinal Chemistry and a PharmD — combining deep molecular science with frontline clinical pharmacology. With 10+ years of experience spanning pharmaceutical research, hospital practice, and biotech, he operates at the rare intersection of bench, computation, and AI.

His core expertise spans the full modern drug design toolkit: from structure-based drug design (SBDD) using receptor crystal structures, molecular docking, and binding site analysis, to ligand-based drug design (LBDD) through pharmacophore modelling, shape similarity, and SAR-driven optimisation. He carries this through reaction enumeration and combinatorial library generation, enabling rapid chemical space exploration, all the way to free energy perturbation (FEP) for high-accuracy binding affinity prediction, applying both physics-based and non-physics-based computational experiments.

What distinguishes Basel is his ability to work fluidly alongside medicinal chemists — translating computational insights into actionable chemistry decisions and, equally, grounding computational models in the synthetic and pharmacological realities that medicinal chemists navigate daily. He speaks both languages: the mathematics of molecular simulation and the intuition of structure–activity relationships. This fluency allows him to serve as a true bridge between computational predictions and experimental design, shortening the feedback loop between virtual hypotheses and real-world chemistry outcomes.

Basel has authored 7 publications (5 peer-reviewed, 2 in submission), with contributions spanning enzyme mechanisms, ADMET prediction, and computational lead optimisation. He believes the future of medicine is built at the boundary of rigorous science and intelligent automation — and he is building it.
Binil Benny
Binil Benny
QSP/PK/PD & PBPK Modelling Scientist · Clinical Pharmacology
Binil is a Clinical Pharmacologist and QSP/PK/PD Modelling Scientist with 5+ years of experience in pharmacometrics, PBPK/QSP modelling, and translational drug development. He holds a Doctor of Pharmacy (PharmD) from Teerthanker Mahaveer University and an MSc in Pharmacology and Drug Discovery from Coventry University.

He currently serves as a PBPK & QSP Modelling Consultant at Vial, developing mechanistic models to support drug development and regulatory decision-making. His expertise includes QSP modelling, PBPK modelling, population pharmacokinetics (PopPK), model-informed drug development (MIDD), and multi-omics data integration.
Karolina Pearson
Karolina Pearson, Ph.D.
Chemical Process Engineer · Hydrogen & Electrochemical Systems · Program Management
Karolina is a Chemical Process Engineer and Technical Program Manager with 10+ years of experience leading complex hydrogen, electrochemical, and catalytic process projects from R&D through pilot- and commercial-scale deployment. She holds a Dr.-Ing. (magna cum laude) in Thermal Process Technology from the University of Stuttgart and an Engineering Diploma in Environmental Engineering.

At Plug Power (Massachusetts), she served as Program Manager across electrolyzer systems and giga-factory automation — overseeing a $83M, 120 MW electrolyzer system delivery, managing a $47M DOE-funded gigawatt-scale electrolyzer manufacturing programme, and leading a 400 MW renewable-powered electrolyzer plant design spanning teams in the US, Europe, UAE, and India. She achieved a 60% manufacturing cost reduction and 25% improvement in testing capacity through automated assembly and in-process quality control.

Earlier, she spent 5 years as a Research Engineer at the German Aerospace Center (DLR) in Stuttgart, developing thermochemical fuel conversion and hydrogen-rich syngas processes for PEM fuel cell systems in aerospace applications, managing an €800K international research project, and publishing in peer-reviewed journals. Her core toolkit includes ASPEN Plus, UniSim, P&ID development, HAZOP/LOPA, and digital twin & data analytics.
Shuai Ma
Shuai Ma
Founding Engineer · AWS · Distributed Systems & LLM Applications
Shuai is an AWS Delivery Lead and Founding Engineer at TakaHuman with 8+ years building distributed systems and LLM applications at scale. He holds an MS in Computer Science from the University of Southern California and previously served as CTO at SYLORA AI, where he led delivery of a clinical AI platform that reduced provider documentation time by 70–80% for 500 users.

At TakaHuman, he architected the job orchestration system for science discovery pipelines and engineered HIPAA and SOC2-compliant data storage and AI workflows for Life Sciences clients in drug discovery and solar design. Prior to this, he spent over 7 years at AWS (Redshift and Managed Services), where he owned roadmap and hiring for an 8-person team, migrated millions of metadata records, and cut CI/CD build times from 60 minutes to under 10.
Anonymous team member
Machine Learning Specialist
LLM & VLM Expert · Proprietary Model Development
A machine learning specialist with deep expertise in large language models (LLMs) and vision-language models (VLMs). This team member leads the development of TakaHuman's proprietary AI models — including the custom LLM and VLM at the core of the platform's scientific reasoning and multi-modal simulation capabilities.

Their background spans cutting-edge model architecture, fine-tuning, and deployment at scale. They have chosen to keep their personal details private at this time.
Anonymous team member
Senior Machine Learning & Full-Stack Engineer
Computer Vision · NLP · Generative AI · Full-Stack Development
A senior machine learning and full-stack engineer with 7+ years of experience across computer vision, NLP, robotics, and full-stack AI development. Currently based in Tokyo, this team member brings hands-on expertise in generative AI, deep learning, and real-world deployment of vision and language systems.

They have built AI vision systems for autonomous robotics, published 13 research papers in computer vision and NLP, and hold industry experience spanning pharma AI, VR product development, and enterprise software engineering. They have chosen to keep their personal details private at this time.
Anonymous team member
Ch. Omar
Full Stack Engineer · Python, React & AWS
Omar is a full-stack engineer with 8+ years building scalable, production-grade applications across healthcare, fintech, and SaaS, using React, Python (Django, FastAPI, Flask), and AWS. He is comfortable owning features end-to-end in fast-moving, ambiguous environments, bringing a founding-team mindset to every engagement — including leading a $500K research platform recognized as a gold standard by the client and doubling client revenue through AI/ML algorithm optimization.

He currently serves as Lead Software Engineer at Eco-Green Developers, architecting Django and PostgreSQL backend systems and leading a distributed team of Python developers, boosting team productivity by 55% and cutting delivery time by 40% through workflow automation. Previously, as Senior Software Engineer & Team Lead at AlignerBase, he built a full-stack platform on Django, Next.js, and PostgreSQL, and as Senior Engineer at Wings Intranet, he built a React Native mHealth app on AWS with a HIPAA-compliant Django REST backend that drove a 50% increase in daily active users. Omar holds a BS in Computer Science from the University of Central Punjab.

Three Moats · Cross-Industry

1
10 Industries in 1 Full Loop
One workflow: idea → hypothesis → simulation → robotic lab → data output → AI training. Not stitched across vendors. Every result feeds the next model — across drugs, batteries, catalysts, space, semis, solar, nuclear, hypersonic, armor, stealth.
2
Physical Data as an Asset
Starting with biology + chemistry data, expanding to all physical domains. Robotic automation compresses the simulation → physical data → AI training loop. The data compounds over time.
3
MOA Equation Generator
The model generates mechanism of action mathematical equations from text information only. Potential to predict kinetics and efficacy of any medicine entering body. Also potential to expand to any material outside of biology.

Why Now

$10–20 Trillion TAM = Physical AI Data Provider

60–100%
Frontier LLM Data Still From Public Web
Open models (Llama 4, DeepSeek V3, Gemma) draw ~100% from Common Crawl. Closed models keep ≥60–70% public-web data plus synthetic.
$15–25T
Hyperscaler AI Capex by 2050
Extrapolated from $725B (2026) → $1.5–2T (2030) at a ~12–15% CAGR.
$10–20T
AI Data + Training Data Subset by 2050
Extrapolated from an estimated $100–200B (2026) → $400–800B (2030) at a similar CAGR.

$71 Trillion TAM = Robotic Systems + Gov + Consumer Health

99%
Of Industries Have Not Adopted L3+
L3+ = closed-loop, AI-driven labs on the 0–5 SDL autonomy scale (analogous to self-driving cars). At L3+, AI runs most experimental steps with minimal human input. Across all 10 core industries we operate in — pharma, batteries, catalysts, semis, solar, space, nuclear, hypersonic, armor, stealth — an estimated 99% still operate at L0–L2.
80%
US Manufacturing Lacks Robotic Automation
80% of U.S. manufacturing facilities have not deployed robotic automation. Globally, 542,000 industrial robots were installed in 2024 (a record), with 2025 installs forecast at ~575,000; U.S. robot density is 307 per 10,000 workers, ranked 8th worldwide.
$25T
Industry R&D + Manufacturing + Labor
Builds on our $7.3T Industry R&D + Manufacturing estimate above, plus the broader labor economy for scientific, technical, and manufacturing roles, extrapolated to 2050.
$6T
Government R&D + Defense
Global government R&D and defense procurement by 2050, extrapolated from a 2024 base of ~$2.7T in military and R&D spending.
$40T
Consumer Health + Pharma
Global healthcare, wellness, and pharma spending by 2050, extrapolated from a 2024 base of ~$15T across healthcare and wellness.

End-to-End Pipeline

1
Early Discovery
AI-powered literature mining, hypothesis generation & scientific target identification across all 10 domains
2
Atomic Simulation
DFT & molecular dynamics simulations at atomic scale — predicting material structure, bonding & quantum behaviour
3
Chemistry · Physics · Biology
Integrated modelling of chemical reactions, physical properties & system-level behaviour across material types
4
Safety
Stability, toxicity, environmental impact & regulatory compliance validation across material categories
5
Manufacture & Scale-Up
Process optimisation, yield modelling & scale-up engineering from lab to commercial production
6
Robotic Lab Synthesis
Autonomous physical materialisation in our robotic labs — turning validated digital designs into real substances

10 Scientific Domains

💊
Medicine
🔋
Batteries
💡
Semiconductors
⚗️
Catalysts
🛰️
Space Energy
☀️
Solar Energy
⚛️
Nuclear Energy
🛡️
Armor
👁️
Stealth
🚀
Hypersonics

R&D + Manufacturing is a $7.3 Trillion Market

Drugs
$2.5T
Pharma (2030)
Batteries
$555B
Battery (2033)
Catalysts
$62B
Catalyst (2033)
Space
$1.8T
Space (2035)
Semiconductors
$1.3T
Semi (2035)
Solar
$868B
Solar PV (2035)
Nuclear
$53B
Nuclear (2034)
Hypersonic
$28B
Hypersonic (2035)
Armor
$54B
Armored veh. (2033)
Stealth
$75B
Stealth warfare (2034)

Sources

R&D + Manufacturing (all forecast, 2030–2035): Grand View Research (Pharma, Battery, Catalyst); WEF/McKinsey Space Economy 2035; Precedence Research (Semi); GM Insights (Solar PV); Fortune Business Insights (Nuclear, Stealth); Market Research Future (Hypersonic); GMI Research (Armored vehicles). Totals reflect R&D + manufacturing revenue by industry.

AI Capex: Hyperscaler capex — Fortune, Bloomberg, Futurum (Q1 2026 earnings). AI data subset — McKinsey AI Infra. Public-web dependency — Pillitteri, “LLM Anatomy in 2026” (June 2026); Toloka, “Foundation Model Training Data” (2026); ODSC, “Top 10 LLM Training Datasets for 2026”; FineWeb2 (Penedo et al., June 2025).

Robotic + Gov + Health: R&D + Mfg TAM — Grand View Research, GM Insights, WEF/McKinsey. Labor — UNESCO, World Bank manufacturing employment data, OECD wages. Government — SIPRI, OECD. Consumer — WHO, Global Wellness Institute, Statista. Adoption — Royal Society Open Science, IFR World Robotics 2025, Deloitte 2025.

Be part of the team
building the next species.

TakaHuman is actively recruiting exceptional people across science, engineering, and operations. This is a rare window — founding-level stock options are available only until our next funding round, expected within the next few months. This deadline is real. This window will not reopen.

1
Founding-Level Stock Options — Limited Time
Any company can offer stock options. Very few can offer them at the founding stage — before any funding round, before any valuation step-up. TakaHuman is making this available now, with a hard deadline tied to our upcoming raise expected within the next few months. If you are considering joining, the time to act is now.
2
Proven Track Record
Dan began his entrepreneurial path at 22 years old, building a track record defined by constant resilience. He has served as an advisor and investor across many startup companies, accumulating deep experience across the full cycle of company building.

Before committing to TakaHuman, Dan spent 1.5 years testing different business ideas across multiple domains. He chose TakaHuman because he identified it as the single most important opportunity available — a platform with the potential to democratise science and create value for all of humanity, while also addressing some of the largest market opportunities in the world.
3
Speed & Pressure
We move fast and that's how we accomplish many things quickly. We operate under pressure and thrive in it. If you want a slow, comfortable environment — this is not it. If you want to do the most important work of your life — and possibly the most important work for humanity, send us a message.
Ready to build the future?

Send us your details and we'll be in touch. All backgrounds welcome — science, engineering, business, and beyond.

We respect your privacy. Information shared here is used solely for recruitment purposes and will not be shared with third parties.

Corporate Info.

Legal Entity
TakaHuman Inc.
C-Corporation · Registered in Delaware, USA
Stage
Majority of 10 domains completed for beta version
Founder
Dan Takahashi
CEO & Founder
Markets
B2C · B2B · Enterprise · Government

Privacy Policy

Last updated: May 21, 2026

The following sets out how TakaHuman Inc. collects, uses, and protects your information.

1. Scope and Roles — For enterprise Customers, TakaHuman typically acts as a processor of Customer Data submitted through the Services, and as a controller for account, billing, and website data.
2. Information We Collect — Account and contact information; service usage information; customer-provided content; communications; website and security data; and sensitive data only with authorisation.

Contact
TakaHuman.

Whether you are a potential customer, partner, researcher, or member of the press — we would love to hear from you.

Send us a message

Fill out the form below and we will get back to you shortly.

By submitting this form, you agree that your information may be used to respond to your enquiry. We will never share your data with third parties.